Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes

Immunologic Research

Volumn 16, Issue 1, 1997, Pages 115-119

  Jenson, A Bennett ^a   Jenson, Michelle C ^a   Cowsert, Lex ^b   Ghim, Shen Je ^b   Sundberg, John P ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Immunodominant epitopes; Papillomavirus; Trimeric and pentameric peptides

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; VIRUS PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CATTLE; IMMUNE RESPONSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRUS IMMUNITY;

EID: 8044229068     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786327     Document Type: Article

References (22)

1. Melnick JL: Summaries on viral taxonomy. published annually in Prog Med Virology. Basel, Switzerland, Karger. 1966-1990.
2. Quinnan GV Jr: Immunology of viral infections, in: Belsche RB (ed): Textbook of Human Virology, ed 1. MA, PSG, 1984, pp 103-108.
3. Summaries on modern vaccines. Lancet, 1990.
4. Anfinsen CB, Scherga HA: Experimental and theoretical aspects of protein folding. Adv Prot Chem 1975;29:205-300.
5. Tainer JA, Getzoff ED, Paterson Y, Olson AJ, Lerner RA: The atomic mobility component of protein antigenicity. Ann Rev Immunol 1985; 3:501-535.
6. Geysen HM, Tainer JA, Rodda SJ, Mason TJ, Alexander H, Getzoff ED, Lerner RA: Chemistry of antibody binding to a protein. Science 1987;235:1184-1190.
7. Getzof ED, Geysen HM, Rodda SJ, Alexander H, Tainer JA, Lerner RA: Mechanisms of antibody binding to a protein. Science 1987; 235: 1191-1196.
8. Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schoofs PG: Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987;102:259-274.
9. Pilacinski VVP, Glassman DL, Krsyzek RA, et al.: Cloning and expression in E. coli of the bovine papillomavirus L1 and L2 open reading frames. Biotechnology 1984;2:356-360.
10. Jenison SA, Firzlaff JM, Langenberg A, Galloway DA: Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. J Virol 1988:62: 2115-2123.
11. Galloway DA, Jenison SA: Characterization of the humoral immune response to genital papillomaviruses. Mol Biol Med 1990;7:59-72.
12. Dillner J, Dillner L, Utter G, Eklund C, Rotola A, Costa S, DiLuca D: Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. Int J Cancer 1990;45: 529-535.
13. Dillner J: Mapping of linear epitopes of human papillomavirus type 16: The E1, E2, E4, E5, E6, and E7 open reading frames. Int J Cancer 1990;46:703-711.
14. Cason J, Patel D, Naylor J, Lunney D, Shepherd PS, Best JM, McCance DJ: Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. J Gen Virol 1989;70:2973-2987.
15. Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L: Antibodies against human papillomavirus type 16 early proteins in human sera: anti E7 reactivity correlates with cervical cancer. J Natl Cancer Inst USA 1989;81:1698-1704.
16. Kreider JW, Howett MK, Wolfe SA, Bartlett GL, Zaino RJ, Sedlace KT, Mortel R: Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminate. Nature (Lond) 1985:317:639-640.
17. Lim P, Jenson AB, Cowsert L, Nakai Y, Lim LY, Jin XW, Sundberg JP: Distribution and specific identification of papillomavirus major capsid protein epitopes by immunohistochemistry and epitope scanning of synthetic peptides. J Infect Dis 1990;162: 1263-1269.
18. Davis D, Chaudhri B, Stephens DM, Carne CA, Willers C, Lachmann PJ: The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. J Gen Virol 1990;71:1975-1983.
19. Cohen BD, Goldstein DJ, Rutledge L, Vass WC, Lowy DR, Schlegel R, Schiller JT. Transformation-specific interactin of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J Virol 1993;67:5303-5311.
20. Andersson T, Sparkowski J, Goldstein DJ, Schlegel R: Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J Biol Chem 1995;270:6830-6837.
21. Sparkowski J, Mense M, Anders J, Schlegel R: E5 oncoprotein transmembrane mutants dissociate fibroblasts transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J Virol 1996;70: 2420-2430.
22. Jenson AB, Lim P, Ghim S, Cowsert L, Olson C, Lim L-Y, Farquhar C, Pilacinski W: Identification of linear epitopes of the BPV-1L1 protein recognized by sera of infected or immunized animals. Pathobiol 1991;59:396-403.